Stay updated with breaking news from Recursion Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological...
Share this article SALT LAKE CITY, March 1, 2021 /PRNewswire/ -- Recursion, a digital biology company industrializing drug discovery, today announced the appointment of R. Martin Chavez as Chairman of its Board of Directors. Dr. Chavez, who joined Recursion's Board of Directors in 2020, will serve as the company's first independent Chairman. In this role, Dr. Chavez will oversee the organization's goals with regard to investor relations and apply his career-long innovation expertise to support Recursion's mission: to decode biology and radically improve lives. "It has been such a pleasure to...